Coronary Heart Disease (CHD) in elderly patients: Which drug to choose, ticagrelor and clopidogrel? a systematic review and meta-analysis of randomized controlled trials
A new generation P2Y12 receptor inhibitor (ticagrelor) is recommended in current therapeutic guidelines to treat patients with coronary heart disease (CHD). However, it is unknown if ticagrelor is more effective than clopidogrel in elderly patients. Therefore, a systematic review was done to assess...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
MDPI
2021
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/33884/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|